AdvaMed - Advanced Medical Technology Association

11/14/2024 | Press release | Distributed by Public on 11/14/2024 10:30

Healionics’ STARgraft Receives FDA Breakthrough Device Designation

Press Releases

Healionics' STARgraft Receives FDA Breakthrough Device Designation

  • EIN Presswire
  • November 14, 2024

Seattle, WA, November 14, 2024 / EINPresswire.com /- Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced that its STARgraft arteriovenous graft - designed to provide a safer and more reliable means of bloodstream access for kidney failure patients needing dialysis - has been granted Breakthrough Device designation by the FDA.

Read more.

Call to Action…
AdvaMed - Advanced Medical Technology Association published this content on November 14, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 14, 2024 at 16:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]